HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhibo Yang Selected Research

Cyclotrons

4/2011Competition between covalent and noncovalent bond cleavages in dissociation of phosphopeptide-amine complexes.
11/2010Effect of the basic residue on the energetics, dynamics, and mechanisms of gas-phase fragmentation of protonated peptides.
10/2008The effect of the secondary structure on dissociation of peptide radical cations: fragmentation of angiotensin III and its analogues.
10/2008Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.
3/2008Energetics and dynamics of electron transfer and proton transfer in dissociation of metal(III)(salen)-peptide complexes in the gas phase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhibo Yang Research Topics

Disease

20Neoplasms (Cancer)
06/2022 - 03/2002
11Breast Neoplasms (Breast Cancer)
09/2005 - 03/2002
8Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 12/2016
6Sudden Infant Death (SID)
04/2011 - 03/2008
3Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2019
2Colonic Neoplasms (Colon Cancer)
05/2022 - 11/2019
2Wounds and Injuries (Trauma)
12/2021 - 10/2021
2Infections
01/2021 - 05/2002
2Neoplasm Metastasis (Metastasis)
01/2020 - 05/2004
1Residual Neoplasm
12/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2021
1Virus Diseases (Viral Diseases)
01/2021
1Inflammation (Inflammations)
01/2021
1COVID-19
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Amyloid Plaque
10/2019
1Leukemia
01/2019
1Capsule Opacification
04/2018
1Melanosis (Freckles)
01/2018
1Atopic Dermatitis (Atopic Eczema)
09/2017
1Skin Diseases (Skin Disease)
12/2016
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2014
1Prostatic Neoplasms (Prostate Cancer)
04/2011

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
06/2022 - 01/2019
6Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2002
5Irinotecan (Camptosar)FDA LinkGeneric
05/2022 - 01/2019
5Peptides (Polypeptides)IBA
10/2019 - 03/2008
4Messenger RNA (mRNA)IBA
01/2020 - 03/2002
4Epidermal Growth Factor (EGF)IBA
01/2004 - 03/2002
3Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2016
3Phosphotransferases (Kinase)IBA
01/2021 - 04/2003
3MicroRNAs (MicroRNA)IBA
01/2021 - 12/2016
3p21-Activated KinasesIBA
04/2005 - 04/2003
3Growth Factor ReceptorsIBA
01/2004 - 04/2003
3LigandsIBA
08/2003 - 03/2002
2LipidsIBA
05/2022 - 01/2017
2IonsIBA
12/2021 - 11/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2021 - 03/2002
2GemcitabineFDA Link
02/2021 - 01/2020
2Long Noncoding RNAIBA
01/2021 - 01/2021
2Biological ProductsIBA
01/2021 - 01/2019
2CateninsIBA
08/2017 - 07/2017
2VancomycinFDA LinkGeneric
01/2009 - 10/2008
2Estrogen ReceptorsIBA
09/2004 - 06/2004
2Estrogen Receptor alphaIBA
06/2004 - 05/2004
2Estrogens (Estrogen)FDA Link
05/2004 - 03/2002
2Tyrosine Kinase InhibitorsIBA
01/2004 - 04/2003
2Gefitinib (Iressa)FDA Link
01/2004 - 04/2003
2ErbB Receptors (EGF Receptor)IBA
01/2004 - 04/2003
1Metformin (Glucophage)FDA LinkGeneric
04/2022
1DNA (Deoxyribonucleic Acid)IBA
04/2022
1Therapeutic UsesIBA
04/2022
1Topoisomerase I InhibitorsIBA
04/2022
1AlginatesIBA
12/2021
1HydrogelsIBA
12/2021
1Collagen Type I (Type I Collagen)IBA
10/2021
1SaponinsIBA
01/2021
1Cornified Envelope Proline-Rich ProteinsIBA
01/2021
1EphrinsIBA
01/2021
1momordinIBA
01/2021
1ProteomeIBA
01/2021
1Zinc Finger E-box-Binding Homeobox 1IBA
01/2020
1IntegrinsIBA
01/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2020
1ZincIBA
01/2020
1JNK Mitogen-Activated Protein KinasesIBA
01/2020
1Amyloid beta-PeptidesIBA
10/2019
1SuspensionsIBA
01/2019
1TOR Serine-Threonine KinasesIBA
04/2018
1Mechanistic Target of Rapamycin Complex 1IBA
04/2018
1Melanins (Melanin)IBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
09/2017
1Interleukin-22 (IL-22)IBA
07/2017
1zhuhuangIBA
12/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2014
1Paclitaxel (Taxol)FDA LinkGeneric
10/2014
1OSW 1IBA
10/2014
1Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
04/2011
1Histidine (L-Histidine)FDA Link
11/2010
1Lysine (L-Lysine)FDA Link
11/2010
1Arginine (L-Arginine)FDA Link
11/2010
1CationsIBA
10/2008
1Diacetyl (Biacetyl)IBA
10/2008
1Anti-Bacterial Agents (Antibiotics)IBA
10/2008
1alanylalanine (Ala-Ala)IBA
10/2008
1Protons (Proton)IBA
03/2008
1AngiotensinsIBA
03/2008
1disalicylaldehyde ethylenediamine (salen)IBA
03/2008
1Mutant Proteins (Protein, Mutant)IBA
09/2005
1Dyneins (Dynein)IBA
06/2005
1PhosphoproteinsIBA
04/2005
1Histones (Histone)IBA
09/2004
1TamoxifenFDA LinkGeneric
06/2004

Therapy/Procedure

6Therapeutics
12/2021 - 08/2003
5Drug Therapy (Chemotherapy)
06/2022 - 12/2019
5Cyclotrons
04/2011 - 03/2008
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 12/2016
1Injections
01/2020
1Lasers (Laser)
10/2019
1Aftercare (After-Treatment)
12/2016